Literature DB >> 10881198

Crystal structure of the BMP-2-BRIA ectodomain complex.

T Kirsch1, W Sebald, M K Dreyer.   

Abstract

Bone morphogenetic proteins (BMPs) belong to the large transforming growth factor-beta (TGF-beta) superfamily of multifunctional cytokines. BMP-2 can induce ectopic bone and cartilage formation in adult vertebrates and is involved in central steps in early embryonal development in animals. Signaling by these cytokines requires binding of two types of transmembrane serine/threonine receptor kinase chains classified as type I and type II. Here we report the crystal structure of human dimeric BMP-2 in complex with two high affinity BMP receptor IA extracellular domains (BRIAec). The receptor chains bind to the 'wrist' epitopes of the BMP-2 dimer and contact both BMP-2 monomers. No contacts exist between the receptor domains. The model reveals the structural basis for discrimination between type I and type II receptors and the variability of receptor-ligand interactions that is seen in BMP-TGF-beta systems.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881198     DOI: 10.1038/75903

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  78 in total

1.  Sequential resonance assignments of the extracellular ligand binding domain of the human TGF-beta type II receptor.

Authors:  A P Hinck; K P Walker; N R Martin; S Deep; C S Hinck; D I Freedberg
Journal:  J Biomol NMR       Date:  2000-12       Impact factor: 2.835

2.  Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions.

Authors:  Thomas B Thompson; Teresa K Woodruff; Theodore S Jardetzky
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

3.  Modifications of human growth differentiation factor 9 to improve the generation of embryos from low competence oocytes.

Authors:  Jing-Jie Li; Satoshi Sugimura; Thomas D Mueller; Melissa A White; Georgia A Martin; Lesley J Ritter; Xiao-Yan Liang; Robert B Gilchrist; David G Mottershead
Journal:  Mol Endocrinol       Date:  2015-01

4.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.

Authors:  David G Winkler; May Kung Sutherland; James C Geoghegan; Changpu Yu; Trenton Hayes; John E Skonier; Diana Shpektor; Mechtild Jonas; Brian R Kovacevich; Karen Staehling-Hampton; Mark Appleby; Mary E Brunkow; John A Latham
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

5.  Covalent binding of BMP-2 on surfaces using a self-assembled monolayer approach.

Authors:  Theresa L M Pohl; Elisabeth H Schwab; Elisabetta A Cavalcanti-Adam
Journal:  J Vis Exp       Date:  2013-08-26       Impact factor: 1.355

6.  Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism.

Authors:  Jennifer N Cash; Elizabeth B Angerman; Henry T Keutmann; Thomas B Thompson
Journal:  Mol Endocrinol       Date:  2012-05-16

Review 7.  Identifying protein interactors in gonadotropin action.

Authors:  James A Dias; Cheryl A Nechamen; Raghad Atari
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

Review 8.  The structures that underlie normal reproductive function.

Authors:  Thomas F Lerch; Min Xu; Theodore S Jardetzky; Kelly E Mayo; Ishwar Radhakrishnan; Ralph Kazer; Lonnie D Shea; Teresa K Woodruff
Journal:  Mol Cell Endocrinol       Date:  2006-11-30       Impact factor: 4.102

9.  Reply to Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.

Authors:  Hikaru Sugimoto; Valerie S LeBleu; Dattatreyamurty Bosukonda; Peter Keck; Gangadhar Taduri; Wibke Bechtel; Hirokazu Okada; William Carlson; Philippe Bey; Mary Rusckowski; Björn Tampe; Desiree Tampe; Keizo Kanasaki; Michael Zeisberg; Raghu Kalluri
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 10.  The DAN family: modulators of TGF-β signaling and beyond.

Authors:  Kristof Nolan; Thomas B Thompson
Journal:  Protein Sci       Date:  2014-06-02       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.